Goldman Sachs raised CEO David Solomon's compensation 26% to $39 million for last year, according to a filing, and its board ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Ultragenyx Pharmaceutical, Inc.

JPMorgan Chase stands head-and-shoulders above the rest of this group of largest U.S. banks by ROAA, while Morgan Stanley runs a pretty close second when its performance is measured by ROTCE. And with ...

Inflation worries remain despite strong earnings as JPMorgan Chase’s Jamie Dimon and David Solomon of Goldman Sachs weigh ...

A raft of U.S. banks reported higher fourth-quarter profits on Friday, extending a winning streak for the industry as an ...

Here are five key things investors need to know to start the trading day: 1. Back on track. The Dow Jones Industrial Average ...

But the grand machinery keeping Wall Street moving is just picking up steam. That's because, deterred by regulatory ...

The CEO also said he is ‘bullish’ on the potential for stock sales, including initial public offerings in 2025.

Goldman Sachs is seeking to end its Apple Card partnership with Apply before their contract expires.

The bank, which owns a minority stake in Viva Wallet, can take over the company in June if its valuation falls before a ...

The banking industry is just about to go into a major change, and investors need to be aware of what is going on. Explore ...

Wall Street paused, with stocks ending little changed. Strong bank earnings keep rolling in and Trump's Treasury pick fields ...